Recent Updates
Recently added Catalysts
SRXH Positive Sentiment

SRx Health Solutions Invests in Astro Investment XVII, an Affiliate of Astro Capital and SPV with Investments in SpaceX and Other Artificial Intelligence and Space Companies

Key Takeaway: SRx Health Solutions has invested over 10% of its capital in Astro Investment XVII, an affiliate of Astro Capital, which focuses on AI and space investments. This move aligns with the company's strategy to leverage high-growth sectors through technology partnerships. The investment is part of a broader merger agreement with EMJ Crypto Technologies, aiming to enhance shareholder value.
Price reaction · baseline $7.176 (2026-05-12 close) · hit pre-market · 2 other SRXH headline(s) in the window, move may be shared
day 0 close · peak
+25.8%
day 1
+15.4%
day 3
+4.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Investment in high-potential sectors like AI and space.
  • Partnership with EMJ Crypto Technologies enhances growth prospects.
  • Confidence expressed by board member in long-term value.

CONCERNS & RISKS

  • Investment is over 10% of investable capital, indicating significant risk.
  • Dependence on market conditions and regulatory approvals for transaction completion.

Full Press Release Details

NORTH PALM BEACH, Fla., May 13, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced it has made an investment of greater than 10% of its investable capital in Astro Investment XVII, an affiliate of Astro Capital and special purpose vehicle (SPV), with investments in SpaceX and other artificial intelligence and space companies.
For more information please visit,Astro Capital.
“This investment demonstrates our belief in the long-term value of both AI and space,” said Michael Young, Board Member of SRx Health. “Our investment in EMJX and Astro Capital provides an avenue to invest in these high potential growth areas through technology and professional managers. We are excited about the opportunities this will present for our shareholders.”
Additional Information and Where to Find ItIn connection with the proposed transaction between the Company has filed with the SEC a Registration Statement on Form S-4 (the "Registration Statement") to register the common stock to be issued in connection with the proposed transaction. The Registration Statement includes an information statement of the Company and a prospectus of the Company (the "Information Statement/Prospectus"), and each of EMJX and the Company may file with the SEC other relevant documents concerning the proposed transaction. After the Registration Statement is declared effective, the definitive Information Statement/Prospectus will be sent to the stockholders This is not a substitute for the Registration Statement, the Information Statement/Prospectus or any other relevant documents that EMJX or the Company has filed or will file with the SEC. BEFORE MAKING ANY INVESTMENT DECISION, INVESTORS AND STOCKHOLDERS OF THE COMPANY ARE URGED TO CAREFULLY AND ENTIRELY READ THE REGISTRATION STATEMENT AND INFORMATION STATEMENT/PROSPECTUS REGARDING THE PROPOSED TRANSACTION AND ANY OTHER RELEVANT DOCUMENTS, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, IF AND WHEN THEY BECOME AVAILABLE, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT EMJX, THE COMPANY, THE PROPOSED TRANSACTION, AND RELATED MATTERS. A copy of the Registration Statement, Information Statement/Prospectus, as well as other relevant documents filed by EMJX and the Company with the SEC, may be obtained free of charge, when they become available, at the SEC's website at www.sec.gov. The information on EMJX's or the Company's respective websites is not, and shall not be deemed to be, a part of this communication or incorporated into other filings either company makes with the SEC.
No Offer or SolicitationThis communication is for informational purposes only and is not intended to and does not constitute an offer to sell or the solicitation of an offer to buy or sell any securities or the solicitation of any proxy, vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act, or in a transaction exempt from the registration requirements of the Securities Act.
Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "believe," "expect," "intend," "aim," "plan," "may," "could," "target," and similar expressions are intended to identify forward-looking statements. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include, but are not limited to, the ability to complete the proposed transaction, shareholder approvals, market conditions, regulatory considerations, and other risks described in the Company's filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them, except as required by law.

Company ContactSRx Health Solutions, Inc.Kent Cunningham, Chief Executive Officer

Investor Relations ContactKCSA Strategic CommunicationsValter Pinto, Managing Director212-896-1254valter@kcsa.com

Frequently Asked Questions

What is the investment made by SRx Health Solutions?

SRx Health Solutions has invested over 10% of its capital in Astro Investment XVII.

What sectors does Astro Investment XVII focus on?

Astro Investment XVII focuses on artificial intelligence and space companies.

Who is SRx Health's partner in this investment?

SRx Health is partnering with EMJ Crypto Technologies for this investment.

What is the purpose of the Registration Statement filed with the SEC?

The Registration Statement is to register common stock related to the proposed transaction.

What risks are associated with SRx Health's investment?

Risks include market conditions, regulatory approvals, and shareholder approvals.

Last updated: May 13, 2026